171 related articles for article (PubMed ID: 2427845)
21. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
van Zyl AI; Jennings AA; Bateman ED; Opie LH
Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825
[TBL] [Abstract][Full Text] [Related]
22. Anti-ischemic effects of celiprolol in patients with exercise-induced angina pectoris.
Douard H; Koch M; Laporte T; Abella ML; Provendier O; Broustet JP
Int J Cardiol; 1989 Oct; 25(1):63-8. PubMed ID: 2571590
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of celiprolol and atenolol on large epicardial coronary arteries in conscious dogs at rest and during exercise.
Drieu la Rochelle C; Giudicelli JF; Berdeaux A
J Cardiovasc Pharmacol; 1993 Jul; 22(1):15-21. PubMed ID: 7690087
[TBL] [Abstract][Full Text] [Related]
24. Clinical and hemodynamic effects of celiprolol in essential hypertension.
Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
[TBL] [Abstract][Full Text] [Related]
25. Haemodynamic dose-response actions of cicloprolol in left ventricular dysfunction due to ischaemic heart disease.
Silke B; Verma SP; Sharma SK; Baig W; Jackson NC; Reynolds G; Frais MA; Taylor SH
Int J Cardiol; 1987 Nov; 17(2):127-36. PubMed ID: 2890589
[TBL] [Abstract][Full Text] [Related]
26. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
[TBL] [Abstract][Full Text] [Related]
27. A single-blind randomized comparison of the 24-h antianginal efficacy of celiprolol versus atenolol.
Jackson NC; Lee PS; Taylor SH
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S145-7. PubMed ID: 2427846
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
Norris RJ
Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
[TBL] [Abstract][Full Text] [Related]
31. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
Riddell JG; Shanks RG; Brogden RN
Drugs; 1987 Oct; 34(4):438-58. PubMed ID: 2890513
[TBL] [Abstract][Full Text] [Related]
32. Clinical performance and therapeutic potential of celiprolol in angina pectoris.
Soberman JE; Frishman WH
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S9-13. PubMed ID: 2481791
[TBL] [Abstract][Full Text] [Related]
33. [Are beta-blockers generally contraindicated in patients with peripheral arterial occlusive disease?].
Schweizer J; Kaulen R; Altmann E; Nierade A; Nanning T
Z Kardiol; 1996 Mar; 85(3):193-7. PubMed ID: 8659199
[TBL] [Abstract][Full Text] [Related]
34. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
[TBL] [Abstract][Full Text] [Related]
35. [Celiprolol in acute myocardial infarct].
Payrhuber K; Kratzer H; Kühn P
Wien Klin Wochenschr; 1986 Mar; 98(6):171-4. PubMed ID: 2871667
[TBL] [Abstract][Full Text] [Related]
36. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
[TBL] [Abstract][Full Text] [Related]
37. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
[TBL] [Abstract][Full Text] [Related]
38. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
[TBL] [Abstract][Full Text] [Related]
39. Effect of atenolol and celiprolol on acetylcholine-induced coronary vasomotion in coronary artery disease.
Burger W; Hampel C; Kaltenbach M; Hartmann A; Herrmann M; Hoffmann JA; Klepzig H
Am J Cardiol; 2000 Jan; 85(2):172-7. PubMed ID: 10955372
[TBL] [Abstract][Full Text] [Related]
40. Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
Silke B; Frais MA; Verma SP; Reynolds G; Taylor SH
Eur J Clin Pharmacol; 1986; 29(6):659-65. PubMed ID: 2872054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
